Systemic Treatment of Non-Small Cell Lung Cancer.
Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. If...
Saved in:
Online Access: |
Full Text (via ProQuest) |
---|---|
Main Author: | |
Format: | eBook |
Language: | English |
Published: |
Oxford University Press, USA,
2012.
|
Series: | Oxford oncology library.
|
Subjects: |
Internet
Full Text (via ProQuest)Online
Call Number: |
RC280.L8 S977 2012
|
---|---|
RC280.L8 S977 2012 | Available |